KLHL42 and synovial sarcoma: However, skin and PB samples from six SS patients, 13 MF patients, seven PE patients, and 10 HCs, as well as multiple cell lines, were used to conduct various validation experiments to further verify the findings for the SC-specific marker genes and KLHL42-associated pathogenesis in CTCL.